CASE REPORT
Published on 09 Sep 2025
Continuous response to maintenance fuzuloparib for germline BRCA2- mutated metastatic pancreatic adenocarcinoma: a case report and literature review
doi 10.3389/fphar.2025.1656670
- 684 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advances in Immunosuppressive Microenvironment Remodeling and Targeted Drug Intervention in Pancreatic Cancer
Advances in Immunosuppressive Microenvironment Remodeling and Targeted Drug Intervention in Pancreatic Cancer
1,699
Total downloads
8,371
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 11 Aug 2025
Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment
doi 10.3389/fimmu.2025.1585858
- 1,331 views
ORIGINAL RESEARCH
Published on 25 Jul 2025
A glycogen derived from sea urchin-Strongylocentyotus internedius shifts macrophages to the M1 phenotype and enhances the anti-pancreatic cancer activity of gemcitabine
doi 10.3389/fphar.2025.1600349
- 906 views
ORIGINAL RESEARCH
Published on 23 May 2025
Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer
doi 10.3389/fendo.2025.1559909
- 1,280 views
SYSTEMATIC REVIEW
Published on 25 Apr 2025
Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024
doi 10.3389/fphar.2025.1564561
- 1,927 views
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: